Taking aim at Ewing's sarcoma: is KIT a target and will imatinib work? [electronic resource]
Producer: 20021211Description: 1660-1 p. digitalISSN:- 0027-8874
- Antineoplastic Agents -- pharmacology
- Benzamides
- Bone Neoplasms -- drug therapy
- Clinical Trials, Phase I as Topic
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- pharmacology
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Piperazines -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-kit -- drug effects
- Pyrimidines -- pharmacology
- Sarcoma, Ewing -- drug therapy
- Treatment Outcome
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.